Open prospective randomized controlled trials on efficacy of dapagliflozin and low carbohydrate diet on glycemic and lipid control
Phase of Trial: Phase II
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 18 Jan 2017 Acording to UMIN,the date for data entry closure is 2018/04/30 and the date for conclusion of data analysis is 2020/12/01.
- 18 Jan 2017 Status changed from not yet recruiting to recruiting.
- 12 Dec 2014 New trial record